arXiv Quantitative Biology @arxiv_bio@qoto.org

Fomite transmission and disinfection strategies for SARS-CoV-2 and related viruses. (arXiv:2005.11443v1 [q-bio.OT]) http://arxiv.org/abs/2005.11443

An Automated, Cost-Effective Optical System for Accelerated Anti-microbial Susceptibility Testing (AST) using Deep Learning. (arXiv:2005.11454v1 [q-bio.QM]) http://arxiv.org/abs/2005.11454

Covid-19: an analysis of an extended SEIR model and a comparison of different intervention strategies. (arXiv:2005.11511v1 [q-bio.PE]) http://arxiv.org/abs/2005.11511

Proofreading through spatial gradients. (arXiv:2005.11615v1 [q-bio.MN]) http://arxiv.org/abs/2005.11615

Impossibility of consistent distance estimation from sequence lengths under the TKF91 model. (arXiv:2005.11625v1 [math.PR]) http://arxiv.org/abs/2005.11625

Protein-ligand interaction study to identify potential dietary compounds binding at the active site of therapeutic target proteins of SARS-CoV-2. (arXiv:2005.11767v1 [q-bio.BM]) http://arxiv.org/abs/2005.11767

Epidemic spreading model of COVID-19. (arXiv:2005.11815v1 [physics.soc-ph]) http://arxiv.org/abs/2005.11815

Repurpose Open Data to Discover Therapeutics for COVID-19 using Deep Learning. (arXiv:2005.10831v1 [q-bio.QM]) http://arxiv.org/abs/2005.10831

Correlated Mixed Membership Modeling of Somatic Mutations. (arXiv:2005.10919v1 [stat.ML]) http://arxiv.org/abs/2005.10919

First passage time study of DNA strand displacement. (arXiv:2005.10925v1 [physics.bio-ph]) http://arxiv.org/abs/2005.10925

Longitudinal laboratory testing tied to PCR diagnostics in COVID-19 patients reveals temporal evolution of distinctive coagulopathy signatures. (arXiv:2005.10938v1 [physics.med-ph]) http://arxiv.org/abs/2005.10938

CovidNet: To Bring the Data Transparency in Era of COVID-19. (arXiv:2005.10948v1 [cs.CY]) http://arxiv.org/abs/2005.10948

A machine learning approach to using Quality-of-Life patient scores in guiding prostate radiation therapy dosing. (arXiv:2005.10951v1 [q-bio.QM]) http://arxiv.org/abs/2005.10951

Avoiding COVID-19: Aerosol Guidelines. (arXiv:2005.10988v1 [physics.soc-ph]) http://arxiv.org/abs/2005.10988

Risk scoring calculation for the current NHSx contact tracing app. (arXiv:2005.11057v1 [cs.CY]) http://arxiv.org/abs/2005.11057

Tractometry-based Anomaly Detection for Single-subject White Matter Analysis. (arXiv:2005.11082v1 [q-bio.QM]) http://arxiv.org/abs/2005.11082

COVID-19: The unreasonable effectiveness of simple models. (arXiv:2005.11085v1 [q-bio.PE]) http://arxiv.org/abs/2005.11085

Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic. (arXiv:2005.10248v1 [q-bio.OT]) http://arxiv.org/abs/2005.10248

Repeat Contacts and the Spread of Disease: An Agent Model with Compartmental Solution. (arXiv:2005.10311v1 [q-bio.PE]) http://arxiv.org/abs/2005.10311

Evolutionary entropy and the Second Law of Thermodynamics. (arXiv:2005.10332v1 [q-bio.PE]) http://arxiv.org/abs/2005.10332